Back to search
FDAFDA · Food and drugs·Recall number Z-3187-2024

Creatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the quantitative determination of creatine kinase (CK) in human serum and plasma. Catalog Number: 07190794190

Published October 2, 2024 · Recall initiated: August 15, 2024

Summary

FDA records medical device Class II recall Z-3187-2024, published October 2, 2024 and initiated August 15, 2024. Recalling firm: Roche Diagnostics Operations, Inc.; Status: Ongoing; Reported quantity: 6504 units; Lot: UDI-DI: 04015630940806 Lot Number: 755471 Exp. Date: 06/30/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Creatine Kinase (CK) Assay Abnormal calibrations on the cobas® c 311/501/502 and COBAS INTEGRA 400 plus Analyzers may lead to erroneous results and misdiagnosis.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Roche Diagnostics Operations, Inc.
Distributor
US Nationwide distribution.
Lot
UDI-DI: 04015630940806 Lot Number: 755471 Exp. Date: 06/30/2024
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Creatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the quantitative determination of creatine kinase (CK) in human serum and plasma. Catalog Number: 07190794190 recalled?

Yes. FDA published recall Z-3187-2024 on October 2, 2024. Reported hazard: Creatine Kinase (CK) Assay Abnormal calibrations on the cobas® c 311/501/502 and COBAS INTEGRA 400 plus Analyzers may lead to erroneous results and misdiagnosis.

What should I do if I have this product?

Voluntary: Firm initiated · Letter